HHS' fight for drug pricing transparency continues amid unmitigated price increases
from Scott E. Rupp
From Sept. 4:
The Department of Health and Human Services recently filed an appeal in hopes of overturning a court decision from June that halted a rule to force drugmakers to list the prices of the drugs they advertise on television. HHS unveiled its plan to require the drug prices in direct-to-consumer TV ads last October and finalized the rule in May. The idea meant that pharmaceutical companies would have to include the wholesale acquisition price for a drug in their television ads if the drug cost exceeded $35 for a one-month supply.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063